ビタミンD療法の世界市場レポート 2025年

ビタミンD療法の市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR13.6％で54億4,000万米ドルに成長します。予測期間における成長の要因としては、継続的な認識と教育、高齢者人口の増加、慢性疾患管理におけるビタミンDの統合、製剤の技術進歩、グローバルヘルスへの取り組み、個別化栄養への注目の高まりなどが挙げられます。予測期間における世界の動向には、骨の健康以外の用途の拡大、サプリメントに対する政府の取り組み、製剤と送達方法の革新、臨床研究とエビデンスに基づく実践への注力、世界市場の拡大などが含まれます。

栄養不良の発生率の上昇が、今後のビタミンD療法市場の成長を牽引すると予測されます。栄養不良には、栄養摂取の欠乏または過剰、必須栄養素の不均衡、または栄養素の利用障害が含まれます。ビタミンDの欠乏は栄養不良の入院患者に顕著に見られ、特に患者がビタミンD治療を受けていない場合、長期死亡率と負の相関関係があります。このように、栄養不良患者の増加により、ビタミンD療法の需要が高まっています。例えば、2024年3月、スイスに本部を置き、健康の促進、世界の安全の確保、社会的弱者への支援を目的とした機関である世界保健機関（WHO）は、2022年、全世界の18歳以上の成人の約3億9,000万人が体重不足で、25億人が太りすぎで、うち8億9,000万人が肥満であると報告しました。5歳から19歳の子供と青少年では、3億9,000万人が太りすぎで、1億6,000万人が肥満と共存し、さらに1億9,000万人が体重不足と分類されました。推定1億4,900万人の5歳未満の子どもたちが発育阻害に苦しんでおり、3,700万人が過体重または肥満と共存しています。5歳未満児の死亡原因の半分近くは栄養不足です。したがって、栄養不良の有病率の増加がビタミンD療法市場の成長を牽引しています。

慢性疾患の有病率の上昇は、将来的にビタミンD療法市場の需要を押し上げると予想されます。慢性疾患は持続性があり、時間の経過とともに進行し、ライフスタイルを変えなければ一般的に悪化します。慢性疾患の例としては、アルツハイマー病、関節リウマチ、パーキンソン病、がんなどがあります。ビタミンD療法は、関連する合併症に対処し、全体的な健康をサポートすることで、慢性疾患を管理するために不可欠です。ビタミンDの欠乏と、心血管疾患、糖尿病、特定のがんなどの慢性疾患のリスク上昇との間に関連性があることを示す研究が数多くあります。十分なビタミンD濃度を維持することは、免疫系の調節、心血管の健康、代謝機能に不可欠です。慢性疾患の患者はビタミンD濃度が低いことが多く、ビタミンDの補給はその管理における貴重な補助手段と考えられています。例えば、2024年5月、米国を拠点とし、がんの研究とトレーニングに重点を置く連邦機関である国立がん研究所（NCI）は、2024年には米国で新たに約200万1,140人ががんと診断され、61万1,720人ががんで死亡すると予想されると報告しました。前立腺がん、肺がん、大腸がんは、2024年に男性で診断されるがん全体の約48％を占めると予測されています。女性の場合、最も多いがんは乳がん、肺がん、大腸がんの3つで、2024年に新たに診断されるがん全体の51％を占めると推定されます。がんサバイバーの数は、2032年までに2,250万人に増加すると予測されています。したがって、慢性疾患の有病率の増加がビタミンD療法市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のビタミンD療法市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のビタミンD療法市場：成長率分析
• 世界のビタミンD療法市場の実績：規模と成長、2019～2024年
• 世界のビタミンD療法市場の予測：規模と成長、2024～2029年、2034年
• 世界のビタミンD療法総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のビタミンD療法市場：投与方法別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口
• 非経口
• 世界のビタミンD療法市場：購入別、実績と予測、2019～2024年、2024～2029年、2034年
• 市販薬
• 処方薬
• 世界のビタミンD療法市場：年齢層別、実績と予測、2019～2024年、2024～2029年、2034年
• 小児
• 成人
• 高齢者
• 世界のビタミンD療法市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 骨粗鬆症
• くる病
• 皮膚疾患
• 筋力低下
• 自己免疫疾患
• 世界のビタミンD療法市場：経口のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ビタミンD3サプリメント（コレカルシフェロール）
• ビタミンD2サプリメント（エルゴカルシフェロール）
• ビタミンD強化食品および飲料
• 世界のビタミンD療法市場：非経口のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 注射用ビタミンD3（コレカルシフェロール）
• 注射用ビタミンD2（エルゴカルシフェロール）
• 静脈内ビタミンD製剤

第7章 地域別・国別分析

• 世界のビタミンD療法市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のビタミンD療法市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ビタミンD療法市場：競合情勢
• ビタミンD療法市場：企業プロファイル
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Torrent Pharmaceuticals Ltd.
• Novartis International AG
• Alkem Laboratories Ltd.
• Sun Pharmaceutical Industries Ltd.
• Cadila Healthcare Ltd.
• Biotics Research Corporation
• Solvay Pharma India Pvt. Ltd.
• Forgo Pharmaceuticals Ltd.
• Mankind Pharmaceuticals Pvt. Ltd.
• Cipla Ltd.
• Ortho Molecular Products
• Zhejiang Garden Biochemical High-tech Co. Ltd.
• Glenmark Pharmaceuticals Ltd.
• Dr. Reddy's Laboratories Ltd.
• Emcure Pharmaceuticals Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ビタミンD療法市場2029年：新たな機会を提供する国
• ビタミンD療法市場2029年：新たな機会を提供するセグメント
• ビタミンD療法市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Vitamin D therapy involves the use of supplements commonly prescribed to treat and prevent vitamin D deficiency. These supplements contribute to the regulation of calcium and phosphorus levels in the body and play a crucial role in maintaining proper bone structure. Vitamin D therapy is also considered in cases of depression where a vitamin D deficiency is identified.

The administration methods for vitamin D therapy include oral and parenteral routes. Oral administration involves ingestion through the mouth. Various purchasing options are available, including over-the-counter (OTC) drugs and prescription drugs. These supplements cater to diverse age groups, including children, adults, and senior citizens, addressing conditions such as osteoporosis, rickets, skin diseases, muscle weakness, and autoimmune disorders.

The vitamin D therapy market research report is one of a series of new reports from The Business Research Company that provides vitamin D therapy market statistics, including vitamin D therapy industry global market size, regional shares, competitors with vitamin D therapy market share, detailed vitamin D therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the vitamin D therapy industry. This vitamin D therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The vitamin d therapy market size has grown rapidly in recent years. It will grow from $2.92 billion in 2024 to $3.27 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increasing awareness of vitamin D deficiency, growing incidence of bone disorders, aging population and osteoporosis prevalence, scientific research highlighting benefits, increase in lifestyle-related diseases, medical recommendations for supplementation.

The vitamin d therapy market size is expected to see rapid growth in the next few years. It will grow to $5.44 billion in 2029 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period can be attributed to continued awareness and education, rising geriatric population, integration of vitamin D in chronic disease management, technological advances in formulations, global health initiatives, increased focus on personalized nutrition. Major trends in the forecast period include expanding applications beyond bone health, government initiatives for supplementation, innovations in formulations and delivery methods, focus on clinical research and evidence-based practices, global market expansion.

The rising incidence of malnutrition cases is anticipated to drive the growth of the vitamin D therapy market in the future. Malnutrition encompasses deficiencies or excesses in nutrient intake, imbalances of essential nutrients, or impaired nutrient utilization. Vitamin D deficiency is notably common among malnourished inpatients and is negatively correlated with long-term mortality, especially when patients are not receiving vitamin D treatment. Consequently, the growing prevalence of malnutrition cases is increasing the demand for vitamin D therapy. For example, in March 2024, the World Health Organization, a Switzerland-based agency dedicated to promoting health, ensuring global safety, and assisting vulnerable populations, reported that in 2022, around 390 million adults aged 18 years and older worldwide were underweight, while 2.5 billion were overweight, including 890 million living with obesity. Among children and adolescents aged 5 to 19 years, 390 million were overweight, with 160 million living with obesity, and another 190 million were classified as thin. An estimated 149 million children under the age of 5 were suffering from stunting, while 37 million were living with overweight or obesity. Nearly half of all deaths among children under 5 years old are linked to undernutrition. Therefore, the increasing prevalence of malnutrition cases is driving the growth of the vitamin D therapy market.

The rising prevalence of chronic diseases is expected to boost the demand for the vitamin D therapy market in the future. Chronic diseases are persistent, progress over time, and typically worsen if lifestyle changes are not made. Examples of chronic diseases include Alzheimer's disease, rheumatoid arthritis, Parkinson's disease, and cancer. Vitamin D therapy is essential in managing chronic diseases by addressing related complications and supporting overall health. Numerous studies indicate a connection between vitamin D deficiency and an elevated risk of chronic conditions such as cardiovascular diseases, diabetes, and certain cancers. Maintaining adequate vitamin D levels is vital for immune system regulation, cardiovascular health, and metabolic function. Individuals with chronic diseases often show lower vitamin D levels, and supplementation is considered a valuable adjunct in their management. For instance, in May 2024, the National Cancer Institute (NCI), a U.S.-based federal agency focused on cancer research and training, reported that in 2024, approximately 2,001,140 new cancer cases will be diagnosed in the United States, with 611,720 people expected to die from cancer. Prostate, lung, and colorectal cancers are projected to account for about 48% of all cancers diagnosed in men in 2024. For women, the three most common cancers will be breast, lung, and colorectal, collectively representing an estimated 51% of all new cancer diagnoses in women in 2024. The number of cancer survivors is anticipated to rise to 22.5 million by 2032. Therefore, the increasing prevalence of chronic diseases is driving the growth of the vitamin D therapy market.

Product innovations are a significant trend gaining traction in the vitamin D therapy market. Major companies in this sector are launching innovative products to maintain their competitive edge. For example, in February 2024, Cadila Pharmaceuticals Pvt Ltd., a multinational pharmaceutical company based in India, introduced its first aqueous formulation, Cadila Pharmaceuticals' Aqueous Cholecalciferol Injection, which sets a new standard in treating vitamin D deficiency. This unique solution provides rapid correction of vitamin D deficiency in a short period. This groundbreaking innovation showcases superior pharmacokinetics (PK) and pharmacodynamics (PD) compared to traditional oil-based cholecalciferol preparations available on the market.

Major companies operating in the vitamin D therapy market are forming partnerships to enhance their market position. A strategic business partnership is a structured alliance between two or more commercial entities, usually established through one or more business agreements or contracts. For example, in July 2024, Catalyst Pharmaceuticals, Inc., a U.S.-based pharmaceutical company, entered into a License, Supply, and Commercialization Agreement with Kye Pharmaceuticals Inc., a Canada-based pharmaceutical company, granting Kye the exclusive Canadian commercial rights to AGAMREE (vamorolone). Vamorolone is utilized in the treatment of Duchenne muscular dystrophy (DMD), which is related to vitamin deficiency.

In June 2022, Nestle Health Science, a Switzerland-based nutritional science company, made an undisclosed acquisition of The Better Health Company (TBHC). This strategic acquisition is anticipated to synergize with Nestle's global portfolio, specifically enhancing its active lifestyle and health & wellness nutrition brands. Additionally, it positions Nestle Health Science to expedite growth by leveraging TBHC's manufacturing facility in Auckland, facilitating the swift introduction of new products into local markets. The Better Health Company, based in the US, brings its expertise in natural health products to complement Nestle's strategic objectives, signaling a strategic move towards bolstering their market presence and product offerings in the health and wellness domain.

Major companies operating in the vitamin d therapy market are Abbott Laboratories, Sanofi SA, GlaxoSmithKline PLC, Pfizer Inc., Merck & Co Inc., Torrent Pharmaceuticals Ltd., Novartis International AG, Alkem Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Biotics Research Corporation, Solvay Pharma India Pvt. Ltd., Forgo Pharmaceuticals Ltd., Mankind Pharmaceuticals Pvt. Ltd., Cipla Ltd., Ortho Molecular Products, Zhejiang Garden Biochemical High-tech Co. Ltd., Glenmark Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Emcure Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Lupin Ltd., Macleods Pharmaceuticals Ltd., Mylan N.V., Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Biocare Medical LLC, Mitsubishi Chemical Group, Zydus Cadila, DSM Nutritional Products AG, BASF SE, Fermenta Biotech Ltd., Taizhou Hisound Pharmaceutical Co. Ltd.

North America was the largest region in the vitamin D therapy market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vitamin d therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vitamin d therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vitamin D therapy market consists of sales of plain vitamin D therapy and active vitamin D analog (or D-hormone) therapy. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vitamin D Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vitamin d therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vitamin d therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vitamin d therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Administration: Oral; Parenteral
• 2) By Purchasing: OTC Drugs; Prescription Drugs
• 3) By Age Group: Children; Adults; Senior Adults
• 4) By Application: Osteoporosis; Rickets; Skin Diseases; Muscle Weakness; Autoimmune Disorders
• Subsegments:
• 1) By Oral: Vitamin D3 Supplements (Cholecalciferol); Vitamin D2 Supplements (Ergocalciferol); Vitamin D Fortified Foods And Beverages
• 2) By Parenteral: Injectable Vitamin D3 (Cholecalciferol); Injectable Vitamin D2 (Ergocalciferol); Intravenous Vitamin D Preparations
• Companies Mentioned: Abbott Laboratories; Sanofi SA; GlaxoSmithKline PLC; Pfizer Inc.; Merck & Co Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vitamin D Therapy Market Characteristics

3. Vitamin D Therapy Market Trends And Strategies

4. Vitamin D Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Vitamin D Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Vitamin D Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Vitamin D Therapy Market Growth Rate Analysis
• 5.4. Global Vitamin D Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Vitamin D Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Vitamin D Therapy Total Addressable Market (TAM)

6. Vitamin D Therapy Market Segmentation

• 6.1. Global Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• 6.2. Global Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• OTC Drugs
• Prescription Grugs
• 6.3. Global Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Children
• Adults
• Senior Adults
• 6.4. Global Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Osteoporosis
• Rickets
• Skin Diseases
• Muscle Weakness
• Autoimmune Disorders
• 6.5. Global Vitamin D Therapy Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vitamin D3 Supplements (Cholecalciferol)
• Vitamin D2 Supplements (Ergocalciferol)
• Vitamin D Fortified Foods And Beverages
• 6.6. Global Vitamin D Therapy Market, Sub-Segmentation Of Parenteral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Vitamin D3 (Cholecalciferol)
• Injectable Vitamin D2 (Ergocalciferol)
• Intravenous Vitamin D Preparations

7. Vitamin D Therapy Market Regional And Country Analysis

• 7.1. Global Vitamin D Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Vitamin D Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vitamin D Therapy Market

• 8.1. Asia-Pacific Vitamin D Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vitamin D Therapy Market

• 9.1. China Vitamin D Therapy Market Overview
• 9.2. China Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vitamin D Therapy Market

• 10.1. India Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vitamin D Therapy Market

• 11.1. Japan Vitamin D Therapy Market Overview
• 11.2. Japan Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vitamin D Therapy Market

• 12.1. Australia Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vitamin D Therapy Market

• 13.1. Indonesia Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vitamin D Therapy Market

• 14.1. South Korea Vitamin D Therapy Market Overview
• 14.2. South Korea Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vitamin D Therapy Market

• 15.1. Western Europe Vitamin D Therapy Market Overview
• 15.2. Western Europe Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vitamin D Therapy Market

• 16.1. UK Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vitamin D Therapy Market

• 17.1. Germany Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vitamin D Therapy Market

• 18.1. France Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vitamin D Therapy Market

• 19.1. Italy Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vitamin D Therapy Market

• 20.1. Spain Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vitamin D Therapy Market

• 21.1. Eastern Europe Vitamin D Therapy Market Overview
• 21.2. Eastern Europe Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vitamin D Therapy Market

• 22.1. Russia Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vitamin D Therapy Market

• 23.1. North America Vitamin D Therapy Market Overview
• 23.2. North America Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vitamin D Therapy Market

• 24.1. USA Vitamin D Therapy Market Overview
• 24.2. USA Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vitamin D Therapy Market

• 25.1. Canada Vitamin D Therapy Market Overview
• 25.2. Canada Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vitamin D Therapy Market

• 26.1. South America Vitamin D Therapy Market Overview
• 26.2. South America Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vitamin D Therapy Market

• 27.1. Brazil Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vitamin D Therapy Market

• 28.1. Middle East Vitamin D Therapy Market Overview
• 28.2. Middle East Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vitamin D Therapy Market

• 29.1. Africa Vitamin D Therapy Market Overview
• 29.2. Africa Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vitamin D Therapy Market Competitive Landscape And Company Profiles

• 30.1. Vitamin D Therapy Market Competitive Landscape
• 30.2. Vitamin D Therapy Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Vitamin D Therapy Market Other Major And Innovative Companies

• 31.1. Torrent Pharmaceuticals Ltd.
• 31.2. Novartis International AG
• 31.3. Alkem Laboratories Ltd.
• 31.4. Sun Pharmaceutical Industries Ltd.
• 31.5. Cadila Healthcare Ltd.
• 31.6. Biotics Research Corporation
• 31.7. Solvay Pharma India Pvt. Ltd.
• 31.8. Forgo Pharmaceuticals Ltd.
• 31.9. Mankind Pharmaceuticals Pvt. Ltd.
• 31.10. Cipla Ltd.
• 31.11. Ortho Molecular Products
• 31.12. Zhejiang Garden Biochemical High-tech Co. Ltd.
• 31.13. Glenmark Pharmaceuticals Ltd.
• 31.14. Dr. Reddy's Laboratories Ltd.
• 31.15. Emcure Pharmaceuticals Ltd.

32. Global Vitamin D Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vitamin D Therapy Market

34. Recent Developments In The Vitamin D Therapy Market

35. Vitamin D Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Vitamin D Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Vitamin D Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Vitamin D Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer